HRP960268B1 - TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO/3,4-c/-1,2,4-TRIAZOLO/4,3-ALPHA/PYRIDINES - Google Patents

TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO/3,4-c/-1,2,4-TRIAZOLO/4,3-ALPHA/PYRIDINES

Info

Publication number: HRP960268B1
Authority: HR; Croatia
Prior art keywords: triazolo; pyrazolo; pyridines; tricyclic; dihydro
Prior art date: 1995-06-06

Application number

HR960268A

Other languages

English (en)

Inventor

Allen Jacob Duplantier

Kelvin Cooper

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-06

Filing date

1996-06-06

Publication date

2002-12-31

1996-06-06 Application filed by Pfizer filed Critical Pfizer

1997-08-31 Publication of HRP960268A2 publication Critical patent/HRP960268A2/hr

2002-12-31 Publication of HRP960268B1 publication Critical patent/HRP960268B1/xx

Links

RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Oncology (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
AIDS & HIV (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

HR960268A 1995-06-06 1996-06-06 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO/3,4-c/-1,2,4-TRIAZOLO/4,3-ALPHA/PYRIDINES HRP960268B1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CA002223624A CA2223624C (en)	1995-06-06	1995-06-06	Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines
PCT/IB1995/000429 WO1996039408A1 (en)	1995-06-06	1995-06-06	TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
HU9601541A HUP9601541A3 (en)	1995-06-06	1996-06-05	Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolol[4,3-a]-pyridines and pharmaceutical compositions containing them

Publications (2)

Publication Number	Publication Date
HRP960268A2 HRP960268A2 (en)	1997-08-31
HRP960268B1 true HRP960268B1 (en)	2002-12-31

Family

ID=89994031

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR960268A HRP960268B1 (en)	1995-06-06	1996-06-06	TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO/3,4-c/-1,2,4-TRIAZOLO/4,3-ALPHA/PYRIDINES

Country Status (43)

Country	Link
US (1)	US6004974A (ko)
EP (1)	EP0837860B1 (ko)
JP (1)	JP3107827B2 (ko)
KR (2)	KR100191972B1 (ko)
CN (1)	CN1061044C (ko)
AP (1)	AP609A (ko)
AR (1)	AR002745A1 (ko)
AT (1)	ATE214700T1 (ko)
AU (1)	AU694871B2 (ko)
BG (1)	BG62568B1 (ko)
BR (1)	BR9602627A (ko)
CA (1)	CA2223624C (ko)
CO (1)	CO4700460A1 (ko)
CZ (1)	CZ287251B6 (ko)
DE (1)	DE69525978T2 (ko)
DK (1)	DK0837860T3 (ko)
DZ (1)	DZ2044A1 (ko)
ES (1)	ES2172583T3 (ko)
FI (1)	FI114097B (ko)
HR (1)	HRP960268B1 (ko)
HU (1)	HUP9601541A3 (ko)
IL (1)	IL118485A (ko)
IS (1)	IS1913B (ko)
LV (1)	LV11620B (ko)
MA (1)	MA23893A1 (ko)
MX (1)	MX9709897A (ko)
MY (1)	MY116527A (ko)
NO (1)	NO306256B1 (ko)
NZ (1)	NZ286734A (ko)
OA (1)	OA10458A (ko)
PL (1)	PL184195B1 (ko)
PT (1)	PT837860E (ko)
RO (1)	RO115881B1 (ko)
RU (1)	RU2161158C2 (ko)
SA (1)	SA96170065B1 (ko)
SG (1)	SG54341A1 (ko)
SI (1)	SI9600186A (ko)
SK (1)	SK282167B6 (ko)
TN (1)	TNSN96083A1 (ko)
TR (1)	TR199600482A1 (ko)
TW (1)	TW460469B (ko)
WO (1)	WO1996039408A1 (ko)
YU (1)	YU49346B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2792938B1 (fr)	1999-04-28	2001-07-06	Warner Lambert Co	NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
US6326495B2 (en) *	1999-04-30	2001-12-04	Pfizer Inc.	Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
EP1380585B1 (en) *	1999-04-30	2004-11-10	Pfizer Products Inc.	Pyrazolopyridinone as intermediate
CA2381802C (en)	1999-08-21	2010-12-07	Byk Gulden Lomberg Chemische Fabrik Gmbh	Synergistic combination of roflumilast and salmeterol
WO2001068600A2 (en) *	2000-03-16	2001-09-20	Inflazyme Pharmaceuticals Limited	Benzylated pde4 inhibitors
MXPA03010791A (es) *	2001-05-25	2004-03-02	Boehringer Ingelheim Pharma	Combinacion de inhibidor de pde4 y tiotropio a sus derivados para tratamiento de enfermedades obstructivas de vias respiratorias y de otras enfermedades inflamatorias.
JP2005508861A (ja) *	2001-05-25	2005-04-07	ファイザー・インク	閉塞性気管疾患の治療のためのｐｄｅ４阻害剤及び抗コリン性剤の組み合わせ物
GB0122031D0 (en) *	2001-09-12	2001-10-31	Pfizer Ltd	Use of pde4 inhibitors in a dry powder inhaler
GB0129395D0 (en) *	2001-12-07	2002-01-30	Pfizer Ltd	Pharmaceutical combination
US20050107420A1 (en) *	2002-05-23	2005-05-19	Boehringe Ingelheim Pharma Gmbh & Co. Kg	Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases
WO2006075748A1 (ja) *	2005-01-17	2006-07-20	Santen Pharmaceutical Co., Ltd.	アレルギー性結膜疾患治療剤
RU2008119323A (ru)	2005-10-19	2009-11-27	Рэнбакси Лабораториз Лимитед (In)	Фармацевтические композиции мускаринового рецептора
CN102764440A (zh)	2006-07-05	2012-11-07	奈科明有限责任公司	用于治疗炎症性肺部疾病的HMG-CoA还原酶抑制剂与磷酸二酯酶4抑制剂的组合
US8653097B2 (en) *	2008-10-17	2014-02-18	Boehringer Ingelheim International Gmbh	Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (P13-kinases) inhibitor
JP5730896B2 (ja) *	2009-12-04	2015-06-10	ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ	トリシクロピラゾール誘導体
WO2013084182A1 (en)	2011-12-08	2013-06-13	Glenmark Pharmaceuticals S.A.	Pharmaceutical composition that includes a pde4 enzyme inhibitor and an analgesic agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3697532A (en) *	1970-08-12	1972-10-10	Squibb & Sons Inc	5-methyldipyrazolo {8 3,4-b;3{40 ,4{40 -d{9 {0 pyridin-3(2h)-ones
HUT74170A (en) *	1993-07-06	1996-11-28	Pfizer	Bicyclic tetrahydro pyrazolopyridines
CA2143143A1 (en) *	1994-03-08	1995-09-09	Toshihiko Tanaka	3-phenylpyrrolidine derivatives

1995
- 1995-06-06 AT AT95918707T patent/ATE214700T1/de not_active IP Right Cessation
- 1995-06-06 MX MX9709897A patent/MX9709897A/es unknown
- 1995-06-06 EP EP95918707A patent/EP0837860B1/en not_active Expired - Lifetime
- 1995-06-06 CA CA002223624A patent/CA2223624C/en not_active Expired - Fee Related
- 1995-06-06 US US08/973,590 patent/US6004974A/en not_active Expired - Fee Related
- 1995-06-06 ES ES95918707T patent/ES2172583T3/es not_active Expired - Lifetime
- 1995-06-06 DE DE69525978T patent/DE69525978T2/de not_active Expired - Fee Related
- 1995-06-06 SK SK718-96A patent/SK282167B6/sk unknown
- 1995-06-06 JP JP08511176A patent/JP3107827B2/ja not_active Expired - Fee Related
- 1995-06-06 PT PT95918707T patent/PT837860E/pt unknown
- 1995-06-06 WO PCT/IB1995/000429 patent/WO1996039408A1/en active IP Right Grant
- 1995-06-06 DK DK95918707T patent/DK0837860T3/da active
1996
- 1996-05-02 TW TW085105271A patent/TW460469B/zh not_active IP Right Cessation
- 1996-05-06 AP APAP/P/1996/000806A patent/AP609A/en active
- 1996-05-20 AR ARP960102626A patent/AR002745A1/es unknown
- 1996-05-27 PL PL96314459A patent/PL184195B1/pl not_active IP Right Cessation
- 1996-05-30 IL IL11848596A patent/IL118485A/xx not_active IP Right Cessation
- 1996-06-03 IS IS4350A patent/IS1913B/is unknown
- 1996-06-04 LV LVP-96-174A patent/LV11620B/en unknown
- 1996-06-04 SA SA96170065A patent/SA96170065B1/ar unknown
- 1996-06-04 BR BR9602627A patent/BR9602627A/pt active Search and Examination
- 1996-06-05 BG BG100640A patent/BG62568B1/bg unknown
- 1996-06-05 KR KR1019960020169A patent/KR100191972B1/ko not_active IP Right Cessation
- 1996-06-05 HU HU9601541A patent/HUP9601541A3/hu unknown
- 1996-06-05 TN TNTNSN96083A patent/TNSN96083A1/fr unknown
- 1996-06-05 MA MA24263A patent/MA23893A1/fr unknown
- 1996-06-05 YU YU34696A patent/YU49346B/sh unknown
- 1996-06-05 NO NO962320A patent/NO306256B1/no unknown
- 1996-06-05 DZ DZ960088A patent/DZ2044A1/fr active
- 1996-06-05 RU RU96111027/04A patent/RU2161158C2/ru not_active IP Right Cessation
- 1996-06-05 CZ CZ19961626A patent/CZ287251B6/cs not_active IP Right Cessation
- 1996-06-05 MY MYPI96002201A patent/MY116527A/en unknown
- 1996-06-05 AU AU54773/96A patent/AU694871B2/en not_active Ceased
- 1996-06-05 SG SG1996009983A patent/SG54341A1/en unknown
- 1996-06-05 NZ NZ286734A patent/NZ286734A/en unknown
- 1996-06-06 HR HR960268A patent/HRP960268B1/xx not_active IP Right Cessation
- 1996-06-06 SI SI9600186A patent/SI9600186A/sl not_active IP Right Cessation
- 1996-06-06 OA OA60834A patent/OA10458A/en unknown
- 1996-06-06 TR TR96/00482A patent/TR199600482A1/xx unknown
- 1996-06-06 CO CO96029521A patent/CO4700460A1/es unknown
- 1996-06-06 CN CN96107630A patent/CN1061044C/zh not_active Expired - Fee Related
- 1996-06-06 RO RO96-01157A patent/RO115881B1/ro unknown
1997
- 1997-12-05 FI FI974434A patent/FI114097B/fi active
1998
- 1998-10-24 KR KR1019980044720A patent/KR100225719B1/ko not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI974434A (fi)	1997-12-05
YU34696A (sh)	1999-07-28
CN1142499A (zh)	1997-02-12
JP3107827B2 (ja)	2000-11-13
TNSN96083A1 (fr)	2005-03-15
CO4700460A1 (es)	1998-12-29
NZ286734A (en)	1998-02-26
RU2161158C2 (ru)	2000-12-27
PT837860E (pt)	2002-07-31
SA96170065B1 (ar)	2005-12-21
NO306256B1 (no)	1999-10-11
HU9601541D0 (en)	1996-07-29
MX9709897A (es)	1998-03-31
CA2223624C (en)	2001-02-20
BR9602627A (pt)	1998-09-01
CN1061044C (zh)	2001-01-24
EP0837860B1 (en)	2002-03-20
BG62568B1 (bg)	2000-02-29
MY116527A (en)	2004-02-28
KR970003440A (ko)	1997-01-28
DZ2044A1 (fr)	2002-07-21
IL118485A0 (en)	1996-09-12
PL184195B1 (pl)	2002-09-30
CA2223624A1 (en)	1996-12-12
PL314459A1 (en)	1996-12-09
KR100191972B1 (ko)	1999-06-15
FI974434A0 (fi)	1997-12-05
JPH10510242A (ja)	1998-10-06
IS1913B (is)	2004-02-03
EP0837860A1 (en)	1998-04-29
IS4350A (is)	1996-12-07
OA10458A (en)	2002-03-27
DK0837860T3 (da)	2002-05-27
SK282167B6 (sk)	2001-11-06
AU5477396A (en)	1996-12-19
HUP9601541A3 (en)	1997-05-28
KR100225719B1 (en)	1999-10-15
HUP9601541A2 (en)	1997-02-28
DE69525978D1 (de)	2002-04-25
LV11620B (en)	1997-04-20
ATE214700T1 (de)	2002-04-15
RO115881B1 (ro)	2000-07-28
NO962320L (no)	1996-12-09
ES2172583T3 (es)	2002-10-01
YU49346B (sh)	2005-07-19
LV11620A (lv)	1996-12-20
AU694871B2 (en)	1998-07-30
HRP960268A2 (en)	1997-08-31
AR002745A1 (es)	1998-04-29
WO1996039408A1 (en)	1996-12-12
CZ162696A3 (en)	1997-01-15
US6004974A (en)	1999-12-21
TR199600482A1 (tr)	1997-03-21
SI9600186A (en)	1997-04-30
SK71896A3 (en)	1997-05-07
DE69525978T2 (de)	2002-12-19
SG54341A1 (en)	1998-11-16
MA23893A1 (fr)	1996-12-31
NO962320D0 (no)	1996-06-05
FI114097B (fi)	2004-08-13
AP609A (en)	1997-09-03
AP9600806A0 (en)	1996-07-31
IL118485A (en)	2000-02-17
CZ287251B6 (en)	2000-10-11
TW460469B (en)	2001-10-21
BG100640A (bg)	1997-03-31

Legal Events

Date	Code	Title	Description
1996-06-06	AIPI	Request for the grant of a patent on the basis of a substantive examination of a patent application
1997-08-31	A1OB	Publication of a patent application
2002-12-31	B1PR	Patent granted
2007-05-28	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20070528 Year of fee payment: 12
2008-12-07	PBON	Lapse due to non-payment of renewal fee	Effective date: 20080607

Publication	Publication Date	Title
EP0648770A3 (de)	1995-05-31	Neue Pyrrolo 3,4-c pyrrole.
HU9501600D0 (en)	1995-07-28	Thieno[1,5]benzodiazepine use
ZA942570B (en)	1994-11-11	1,5 benzodiazepine derivatives
HU9403364D0 (en)	1995-02-28	Imidazopyridine
HRP960268B1 (en)	2002-12-31	TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO/3,4-c/-1,2,4-TRIAZOLO/4,3-ALPHA/PYRIDINES
ZA949664B (en)	1995-08-15	Imidazopyridines
IL115667A0 (en)	1996-01-19	Bicyclic tetrahydro pyrazolopyridines
IL116773A0 (en)	1996-05-14	Tricyclic benzazepine compounds and their preparation
EP0730596A4 (en)	1997-07-30	BENZODIAZEPINES
HU9300488D0 (en)	1993-05-28	Tricyclic benzodiazepine derivatives
ZA943996B (en)	1995-02-06	Imidazopyridines
AP9400657A0 (en)	1994-07-31	1,5 benzodiazepine derivatives
GR3037060T3 (en)	2002-01-31	2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives
ZA939291B (en)	1995-06-09	Diazepine derivatives
HK1018057A1 (en)	1999-12-10	Tricyclic benzazepine compounds
EP0745086A4 (en)	1997-08-13	TRICYCLIC SPIROPIPERIDINES
GB9317692D0 (en)	1993-10-13	Benzodiazepine derivatives
GB9320113D0 (en)	1993-11-17	Tricyclic derivatives
GB9310428D0 (en)	1993-07-07	Tricyclic cefem sulphones
ZA94382B (en)	1995-07-19	Tricyclic 1,2,4-triazolo compounds
ZA964649B (en)	1997-12-05	Tricyclic 5,6-dihydro-9H-pyrazolo[3,4c]-1,2,4-triazolo[4,3a]pyridines.
ZA948093B (en)	1995-06-05	Tricyclic 1-aminoethylpyrrol -derivatives
GB9308013D0 (en)	1993-06-02	Benzodiazepine derivatives
GB9322270D0 (en)	1993-12-15	Benzodiazepine derivatives
GB9312311D0 (en)	1993-07-28	New benzodiazepine derivatives